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ABSTRACT
Congenital heart disease (CHD) is one of the most common congenital anomalies with an incidence of ap-
proximately 8–10 cases per 1000 live births. The etiology behind cardiac developmental disturbances is un-
known for a majority of cases.
  It is known that children with CHD frequently require regular long-term medication, but the knowledge 
of oral health effects, caused by long-term medication in medically compromised children, is sparse.  If left 
untreated, CHD is the single greatest cause of death during the neonatal period after full-time pregnancies 
in the industrialized part of the world.
  A number of studies have been carried out on the caries prevalence in children with CHD, but only five of 
them were controlled studies. According to one of them children with CHD had a higher number of regis-
tered periodontal sites with plaque and gingival inflammation than the healthy control group of children, 
although nearly all examined patients had plaque registered. Children with CHD had higher mean values of 
dmft/DMFT indices than healthy children and only a few of them had dental fillings, indicating an unmet 
need for operative treatment. 
  Today surgical treatment is successful for the majority of children born with CHD. The median age of 
children subjected to heart surgery today is below 2 years of age. We need to continuously improve the 
oral health by providing education and training for both dental and medical health care specialists on oral 
health problems and their prevention in this new group of patients.
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CONGENITAL HEART DISEASES – 
DEFINITION, ETIOLOGY, CLASSIFI-
CATION AND PREVALENCE
The human heart develops between 8th and 12th 
gestational week and disturbances in this process 
may cause an anomaly – a congenital heart disease 
(CHD). CHD is one of the most common congenital 
anomalies with an incidence of approximately 8-10 
cases per 1000 live births (1-7). Children with com-
plex anomalies represent approximately one third 
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of all CHD cases (1-5). The ongoing technical and 
methodological improvements in surgery have led 
to the possibility for early surgical interventions and 
lower morbidity rates among children with CHD (1-
3,5,8). The majority of children with CHD nowadays 
are subjected to successful surgery, but for many of 
them, suffering from complex CHD, surgery is only a 
palliative treatment (9,10).
The etiology behind CHD stays unknown for 
the majority of cases, but there are some possible risk 
factors such as diseases and infections of the moth-
er like rubella, diabetes, HIV and chronic intoxica-
tions, that have been reported (11,6). Many CHDs 
are hereditary but modified by extrinsic factors (7). 
In most of the cases CHD occurs as an isolated im-
pairment, but it can also be a part of a syndrome or 
of some genetic malformations such as Down’s syn-
drome, Noonan’s syndrome, Turner’s syndrome and 
trisomy 18. Approximately 40% of children suffering 
from Dowǹ s syndrome and trisomy 18 have a CHD 
(12,13).
The most common cardiac developmental dis-
turbances may be classified in three sub-groups as fol-
lows: CHD with left-right shunt, CHD with right-left 
shunt, and obstructive heart diseases (Table 1) (2,14).
Congenital heart anomalies represent 28% of 
all congenital anomalies (3,15). The mean incidence 
is 8 out of 1000 (2,3,12). A meta-analysis of online 
specialized database from 2011 reviewed 114 online 
sources and revealed rising levels of the prevalence of 
CHD for the period 1930-1995, from 0.6 to 9 out of 
every 1000 live births (3,12). 
A scientific research in Sudan (2007) reveals 
that the prevalence of CHD among Sudanese chil-
dren aged 5-15 is 2 out of every1000 live births (3,16). 
In 2013, the most common CHDs are represented by 
atrioventricular septal defect (AVSD), ventricle sep-
tal defect (VSD), patent ductus arteriosus (PDA), 
pulmonary stenosis (PS) and tetralogy of Fallot and 
comprise up to 83% all CHDs in Sudan (2). 
There is not enough epidemiological data 
concerning CHDs in Bulgaria. Citing the register of 
congenital anomalies for the region of Pleven (2011), 
the prevalence of CHD is found to be 5-6 out of every 
1000 live births (2). During an epidemiological re-
search of Pilosof V. et al. (1979), concerning 6 regions 
of Bulgaria, the prevalence of CHD was measured 
to be 7.4/1000 (2,3). According to the same sources 
12.5% of all CHD were critical. 
Symptoms of CHD
 The main symptoms of CHD are cyanosis and/
or heart failure. In cyanosis, de-oxygenated blood 
is mixed with oxygenated blood or an increased 
amount of blood goes to the pulmonary circulation 
(7). Low saturation in tissues and organs may lead to 
acidosis, and this may cause an impaired heart func-
tion and heart failure (3,6).
Heart failure is either due to an increased 
blood flow to the pulmonary circulation or due to 
a deformed ventricle, which fails to keep the pump-
ing function. Blood will fill the lungs, and breath-
ing will be affected. The clinical signs are tachypnea 
and tachycardia, feeding problems, and inadequate 
weight gain. The first symptoms of heart failure are 
often observed during the child’s first 3 months of 
life (2,3).
Common Clinics and Oral Manifestations of 
Common CHDs
According to a research from 2016, bicuspid 
aortic valve (BAV) is the most common CHD. BAV 
Classification of congenital heart diseases according to Abbott
I. CHD with left-right shunt 
1. Ventricle septal defect (VSD)
2. Atrial septal defect (ASD)
3. Patent ductus arteriosus (PDA)
4. Atrioventricular septal defect (AVSD)
II. CHD with right-left shunt (Cyanotic vitia) 1. Tetralogy of Fallot (TOF)2. Transposition of the great arteries (TGA) 
III. CHD without a shunt (Obstructive heart diseases) 
1. Aortic stenosis (AS)
2. Coarctation of the aorta (CоА)
3. Pulmonary stenosis (PS)
Table 1. Classification of congenital heart malformations according to Abbott
Prevalence of Dental Decay and Periodontal Diseases Among Children Suffering from Congenital Heart Diseases. ...
38 Scripta Scientifica Medicinae Dentalis, 2017;3(2):36-40 
Medical University of Varna
is an inherited form of heart disease in which two 
of the leaflets of the aortic valve fuse during devel-
opment in the womb resulting in a two-leaflet valve 
(bicuspid valve) instead of the normal three-leaflet 
valve (tricuspid) (17-21). BAV is not only due to a de-
fect during embryogenesis (congenital) but is usual-
ly a part of more complex genetically induced dis-
turbances of heart̀ s development (inherited) (19,21). 
The morphogenesis of the heart and its valves takes 
place in an early stage of the embryotic development 
(19,20) and BAV presents a disturbance in meso-
dermal tissue (19,22). BAV may be present as a part 
of Williams̀  or Turner̀ s syndrome (19,21,23). The 
gravity of clinical symptoms may vary from asymp-
tomatic state during the period of lactation and ear-
ly childhood to grave disturbances in the valve func-
tion in elders (19,21,23,24). Typical symptoms after 
entering puberty are syncopes, angina pectoralis and 
breathing difficulties (19,21,24,25). 
A clinical research presents a case of a patient 
with BAV, observed from childhood till puberty. The 
gravity of clinical symptoms of the CHD increased 
in time, and by the time of puberty the patient al-
ready had the three typical symptoms present (syn-
copes, angina pectoralis and breathing difficulties). 
The only impairment observed during early child-
hood was hypodontia of the upper lateral primary 
incisors. Worsening of the aortic stenosis led to inad-
equate growth and weight gain (compared to healthy 
children of the same age) and immature ossification 
of the wrist bones (the skeletal age – 7 was lower than 
the biological one – 9 years of age) (19).
TREATMENT OF CHD
Surgical Treatment
The first pediatric cardiac surgery was per-
formed in 1938. The first heart-lung machine was 
used in 1953, and since 1970 pacemaker and heart 
transplantations on newborns have been used in pe-
diatric cardiology. During the 1980s, some cathe-
ter surgeries for CHD became possible.  The use of 
prostaglandin on patients with duct-dependent heart 
anomalies and the development of diagnostic echo-
cardiography changed the prognosis for children 
with CHD and increased their survival rate. Today, 
even children born with very complex CHD, may 
have successful surgery (2,3,19). Nowadays, the mean 
age for cardiac surgery is below 2 years of age (2,3,6).
Pharmacological Treatment
If left untreated, CHD is the main reason for 
death in the neonatal period in the industrialized 
part of the world (6,7). 
Diuretics are the first medication of choice for 
treatment of heart failure, because they diminish the 
overall blood volume and thus decrease heart load-
ing. Therapy with angiotensin-converting enzyme 
inhibitors (ACE-inhibitors) and/or cardiac glyco-
sides may also be indicated for heart failure. ACE-
inhibitors prevent angiotensin II formation and thus 
decrease the peripheral resistance both during pre-
load and afterload (26-28). Digitalis preparations 
lower the heart rate and stimulate the contractility 
of the heart muscle. Beta-blockers are used for treat-
ment of cardiac arrhythmias and may be prescribed 
as adjunct therapy for heart failure (30-32). Anti-co-
agulants such as warfarin, which hinders blood clot 
formation, and anti-platelet drugs such as acetylsal-
icylic acid, decrease platelet aggregation. They are 
used to prevent thrombotic events for diagnosed car-
diovascular diseases (26-28).
For CHD with communication between left 
and right heart present, for pulmonary stenosis or for 
hypoplastic left heart syndrome, the patency of the 
ductus is crucial, otherwise the child is going to die. 
In the late 1970s prostaglandin was found to man-
age this patency of the arterial canal and thus dra-
matically improved the results of pediatric cardiac 
surgery. After prostaglandin infusion, children with 
CHD can be successfully stabilized and transport-
ed to appropriate surgery under better circumstanc-
es (28).
Pharmaceutical preparations, used for children 
with complex CHD, are usually combined. The most 
commonly used medications in pediatric cardiology 
are listed in Table 2 (26-28).
Risk Factors for Decay and/or Periodontal 
Disease Occurrence in Children with CHD
The potential risk factor is a variable related to 
a higher risk of infection and/or disease. The expo-
sure to the potential risk factor must be present by 
the time of the resulting disease and this implies the 
need for prospective studies to prove them as actu-
al risk factors (29). Lowered salivary flow and high 
numbers of acidogenic oral flora are well known risk 
factors for decay and/or periodontal disease occur-
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rence. The gravity of the risk factors for decay forma-
tion varies in time for they are affected by behavior-
al habits. Poor oral hygiene habits, inadequate diet, 
long-term medication with sugar- and/or acid-con-
taining preparations, or xerogenic ones, are all prop-
er examples of behavioral habits that lead to higher 
risk of decay formation (33).
There are a few risk factors linked to children 
with CHD, which by themselves or in a combination, 
may lead to a greater possibility of decay formation: 
1. inadequate weight gain and hindered growth, 
usually managed with extra feedings even dur-
ing night time (30,31);
2. long-term medication with peroral antibiotics, 
which contain saccharose (30);
3. reduced salivary flow, caused by medical prepa-
rations used in pediatric cardiology (10,30); 
4. parents are mainly concerned with the cardiac 
disease and neglect oral health (30).
In addition, a recent study on a group of chil-
dren with CHD proves that the enamel and dentine 
of their primary teeth were structurally and chem-
ically different from normal ones, presenting low-
er values of overall calcium and phosphates levels 
(30,32,34).
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